Mark E. Tryniski - Nov 5, 2021 Form 4 Insider Report for CONMED Corp (CNMD)

Role
Director
Signature
Sarah M Oliker for Mark E. Tryniski by Power of Attorney
Stock symbol
CNMD
Transactions as of
Nov 5, 2021
Transactions value $
-$1,182,424
Form type
4
Date filed
11/8/2021, 07:59 PM
Previous filing
Sep 16, 2021
Next filing
Mar 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNMD Common Stock Options Exercise $254K +4.89K +58.97% $51.90 13.2K Nov 5, 2021 Direct
transaction CNMD Common Stock Sale -$750K -4.79K -36.34% $156.51 8.4K Nov 5, 2021 Direct F1
transaction CNMD Common Stock Sale -$15.7K -100 -1.19% $157.11 8.3K Nov 5, 2021 Direct
transaction CNMD Common Stock Options Exercise $235K +3.4K +40.97% $69.03 11.7K Nov 5, 2021 Direct
transaction CNMD Common Stock Sale -$454K -2.9K -24.79% $156.44 8.8K Nov 5, 2021 Direct F2
transaction CNMD Common Stock Sale -$78.5K -500 -5.68% $157.06 8.3K Nov 5, 2021 Direct F3
transaction CNMD Common Stock Options Exercise $231K +2.89K +34.79% $79.94 11.2K Nov 5, 2021 Direct
transaction CNMD Common Stock Sale -$373K -2.39K -21.34% $156.44 8.8K Nov 5, 2021 Direct F4
transaction CNMD Common Stock Sale -$78.5K -500 -5.68% $156.95 8.3K Nov 5, 2021 Direct F5
transaction CNMD Common Stock Options Exercise $136K +1.84K +22.22% $73.94 10.1K Nov 5, 2021 Direct
transaction CNMD Common Stock Sale -$273K -1.74K -17.19% $156.48 8.4K Nov 5, 2021 Direct F6
transaction CNMD Common Stock Sale -$15.7K -100 -1.19% $157.05 8.3K Nov 5, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -4.89K -100% $0.00* 0 Nov 5, 2021 Common Stock 4.89K $51.90 Direct F7
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -3.4K -100% $0.00* 0 Nov 5, 2021 Common Stock 3.4K $69.03 Direct F7
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -2.89K -100% $0.00* 0 Nov 5, 2021 Common Stock 2.89K $79.94 Direct F7
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -1.84K -100% $0.00* 0 Nov 5, 2021 Common Stock 1.84K $73.94 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.01 to $156.96. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.82 to $156.81. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.83 to $157.37. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.81 to $156.76. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.86 to $157.12. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.01 to $156.96. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F7 The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.
F8 The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.